N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes

Circulation

Volumn 110, Issue 2, 2004, Pages 128-134

  Galvani, Marcello ^a,k   Ottani, Filippo ^a   Oltrona, Luigi ^b   Ardissino, Diego ^c   Gensini, Gian Franco ^d   Maggioni, Aldo P ^e   Mannucci, Pier Mannuccio ^f   Mininni, Nicola ^g   Prando, Maria Domenica ^h   Tubaro, Marco ⁱ   Vernocchi, Arialdo ^a   Vecchio, Carlo ^j  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e ANMCO RESEARCH CENTER   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g MONALDI HOSPITAL   (Italy)

^h MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

ⁱ SAN FILIPPO NERI HOSPITAL   (Italy)

^j GALLIERA HOSPITAL   (Italy)

^k Fondazione Cardiologica Sacco   (Italy)

more..

Author keywords

Myocardial infarction; Natriuretic peptides; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PROTEIN PRECURSOR; TROPONIN T; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEATH; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERSISTENT ST SEGMENT ELEVATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; ST SEGMENT ELEVATION; STATISTICAL MODEL;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; ODDS RATIO; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME; TROPONIN T;

EID: 3142752668     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000134480.06723.D8     Document Type: Article

References (20)

1. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23:1809-1840.
2. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2003;24:28-66.
3. Singh M, Reeder GS, Jacobsen SJ, et al. Scores for post-myocardial infarction risk stratification in the community. Circulation. 2002;106:2309-2314.
4. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:316-322.
5. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf). 1997;47:287-296.
6. McMurray J, Davie AP, McClure SJ. Assessment of heart failure with plasma natriuretic peptides. Lancet. 1998;351:444; discussion 445.
7. Bay M, Kirk V, Parner J, et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 2003;89:150-154.
8. Richards AM, Nicholls MG, Espiner EA, et al. B-Type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation. 2003;107:2786-2792.
9. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014-1021.
10. Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol. 2002;40:437-445.
11. Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106:2913-2918.
12. Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol. 2002;89:463-465.
13. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation. 2003;108:275-281.
14. de Lemos JA, Morrow DA. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes. Rev Cardiovasc Med. 2003;4(suppl 4):S37-S46.
15. Tateishi J, Masutani M, Ohyanagi M, et al. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol. 2000;23:776-780.
16. Kyriakides ZS, Markianos M, Michalis L, et al. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol. 2000;23:285-288.
17. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol. 2003;41:1264-1272.
18. Talwar S, Squire IB, Downie PF, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction: correlation with left ventricular systolic dysfunction. Eur Heart J. 2000;21:1514-1521.
19. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976-982.
20. Jernberg T, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol. 2003;42:1909-1916.